Kevin R Sayer Dexcom Inc (DXCM) insider trading activity

Kevin R Sayer is Chairman, CEO & President of DEXCOM INC. Currently has a direct ownership of 372,029 shares of DXCM, which is worth approximately $24.6 Million. The most recent transaction as insider was on Nov 12, 2021, when has been sold 3,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 372K

31.05% 3M change

31.05% 12M change

Total Value Held $24.6 Million

KEVIN R SAYER Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 12 2021	SELL Bona fide gift	-	3,000 Reduced 3.31%	87,705 Common Stock
Oct 15 2021	SELL Open market or private sale	$3,302,340 $550.39 p/Share	6,000 Reduced 6.2%	90,705 Common Stock
Sep 15 2021	SELL Open market or private sale	$3,241,680 $540.28 p/Share	6,000 Reduced 5.84%	96,705 Common Stock
Sep 09 2021	SELL Open market or private sale	$1,633,162 $541.32 p/Share	3,017 Reduced 2.85%	102,705 Common Stock
May 03 2021	SELL Open market or private sale	$2,106,234 $380.53 p/Share	5,535 Reduced 4.97%	105,722 Common Stock
Apr 05 2021	SELL Open market or private sale	$2,280,868 $366.64 p/Share	6,221 Reduced 5.3%	111,257 Common Stock
Mar 10 2021	SELL Open market or private sale	$5,096,849 $362.92 p/Share	14,044 Reduced 10.68%	117,478 Common Stock
Mar 09 2021	SELL Open market or private sale	$1,391,837 $360.86 p/Share	3,857 Reduced 2.85%	131,522 Common Stock
Mar 08 2021	BUY Grant, award, or other acquisition	-	13,445 Added 9.03%	135,379 Common Stock
Feb 17 2021	SELL Bona fide gift	-	10,000 Reduced 7.58%	121,934 Common Stock
Feb 01 2021	SELL Open market or private sale	$4,699,563 $376.93 p/Share	12,468 Reduced 8.63%	131,934 Common Stock
Jan 13 2021	SELL Open market or private sale	$2,511,269 $355.05 p/Share	7,073 Reduced 4.67%	144,402 Common Stock
Jan 12 2021	SELL Open market or private sale	$14,417,594 $360.9 p/Share	39,949 Reduced 20.87%	151,475 Common Stock
Jan 08 2021	BUY Grant, award, or other acquisition	-	75,910 Added 28.4%	191,424 Common Stock
Dec 01 2020	SELL Open market or private sale	$4,263,673 $322.2 p/Share	13,233 Reduced 10.28%	115,514 Common Stock
Oct 29 2020	SELL Open market or private sale	$4,754,062 $343.75 p/Share	13,830 Reduced 9.7%	128,747 Common Stock

KRS

Kevin R Sayer

Chairman, CEO & President

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DXCM shares.

Notify only if

Value

Insider Trading

Get notified when an Dexcom Inc insider buys or sells DXCM shares.

Notify only if

Operation

Value

Type

News

Receive news related to DEXCOM INC

Track Activities on DXCM

Account